NeuroPace (NPCE) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $12.78, +1.75% vs the prior close of $12.56.
- Volume 86.60K shares, 0.6x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
NPCE rises 1.8% to $12.78. Closed at $12.78, +1.75% vs the prior close of $12.56. Day range $12.51–$13.00, opened at $12.51.
NPCE daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — NPCE rises 1.8% to $12.78
- Closed at $12.78, +1.75% vs the prior close of $12.56. Day range $12.51–$13.00, opened at $12.51.
- Volume was 86.60K shares, 0.6x its 50-day average of 143.64K.
- Price is -9.0% vs its 50-day average ($14.04) and -15.7% vs its 200-day average ($15.16).
- 52-week range $9.22–$19.60; today's close sits at 34% of that range, 34.8% below the 52-week high.
Oct 14, 2026 — NPCE dips 0.9% to $12.56
- Closed at $12.56, -0.95% vs the prior close of $12.68. Day range $12.48–$13.04, opened at $12.58.
- Volume was 90.00K shares, 0.6x its 50-day average of 147.35K.
- Price is -10.7% vs its 50-day average ($14.06) and -17.3% vs its 200-day average ($15.18).
- 52-week range $9.22–$19.60; today's close sits at 32% of that range, 35.9% below the 52-week high.
Oct 13, 2026 — NPCE dips 2.5% to $12.68
- Closed at $12.68, -2.46% vs the prior close of $13.00. Day range $12.68–$13.27, opened at $13.06.
- Volume was 66.80K shares, 0.4x its 50-day average of 157.89K — lighter than usual.
- Price is -10.0% vs its 50-day average ($14.09) and -16.6% vs its 200-day average ($15.20).
- 52-week range $9.22–$19.60; today's close sits at 33% of that range, 35.3% below the 52-week high.
Oct 12, 2026 — NPCE rises 2.6% to $13.00
- Closed at $13.00, +2.60% vs the prior close of $12.67. Day range $12.48–$13.02, opened at $12.52.
- Volume was 63.30K shares, 0.4x its 50-day average of 163.26K — lighter than usual.
- Price is -7.8% vs its 50-day average ($14.11) and -14.6% vs its 200-day average ($15.21).
- 52-week range $9.22–$19.60; today's close sits at 36% of that range, 33.7% below the 52-week high.
Oct 9, 2026 — NPCE rises 2.3% to $12.67
- Closed at $12.67, +2.26% vs the prior close of $12.39. Day range $12.38–$12.70, opened at $12.39.
- Volume was 72.50K shares, 0.4x its 50-day average of 166.39K — lighter than usual.
- Price is -10.2% vs its 50-day average ($14.10) and -16.8% vs its 200-day average ($15.23).
- 52-week range $9.22–$19.60; today's close sits at 33% of that range, 35.4% below the 52-week high.
Oct 8, 2026 — NPCE dips 2.9% to $12.39, a 6-month low
- Closed at $12.39, -2.90% vs the prior close of $12.76. Day range $12.28–$12.66, opened at $12.66.
- Volume was 142.60K shares, 0.8x its 50-day average of 170.87K.
- Price is -12.3% vs its 50-day average ($14.13) and -18.8% vs its 200-day average ($15.25).
- 52-week range $9.22–$19.60; today's close sits at 31% of that range, 36.8% below the 52-week high.
Oct 7, 2026 — NPCE rises 0.7% to $12.76
- Closed at $12.76, +0.71% vs the prior close of $12.67. Day range $12.51–$13.06, opened at $12.58.
- Volume was 127.20K shares, 0.7x its 50-day average of 171.40K.
- Price is -9.8% vs its 50-day average ($14.15) and -16.4% vs its 200-day average ($15.27).
- 52-week range $9.22–$19.60; today's close sits at 34% of that range, 34.9% below the 52-week high.
Oct 6, 2026 — NPCE slides 4.2% to $12.67, a 6-month low
- Closed at $12.67, -4.16% vs the prior close of $13.22. Day range $12.66–$13.38, opened at $13.38.
- Volume was 83.00K shares, 0.5x its 50-day average of 172.61K — lighter than usual.
- Price is -10.8% vs its 50-day average ($14.20) and -17.1% vs its 200-day average ($15.29).
- 52-week range $9.22–$19.60; today's close sits at 33% of that range, 35.4% below the 52-week high.
Oct 5, 2026 — NPCE jumps 4.1% to $13.22
- Closed at $13.22, +4.09% vs the prior close of $12.70. Day range $12.50–$13.26, opened at $12.64.
- Volume was 149.40K shares, 0.9x its 50-day average of 175.00K.
- Price is -7.3% vs its 50-day average ($14.25) and -13.6% vs its 200-day average ($15.30).
- 52-week range $9.22–$19.60; today's close sits at 39% of that range, 32.6% below the 52-week high.
Oct 2, 2026 — NPCE slides 3.4% to $12.70, a 6-month low, 4 down days in a row
- Closed at $12.70, -3.42% vs the prior close of $13.15. Day range $12.68–$13.34, opened at $13.34.
- Volume was 120.40K shares, 0.7x its 50-day average of 183.66K.
- Price is -11.1% vs its 50-day average ($14.29) and -17.1% vs its 200-day average ($15.31).
- 52-week range $9.22–$19.60; today's close sits at 34% of that range, 35.2% below the 52-week high.
- That makes 4 straight losses.
NPCE latest news & SEC filings
Every SEC filing by or about NPCE in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 25, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Morrell Martha had withheld for taxes 335 shares at $13.97 (≈$4.68K) on Sep 24, 2026; now holds 51,357
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 21, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Williams Patrick F. had withheld for taxes 1,162 shares at $14.28 (≈$16.59K) on Sep 20, 2026; now holds 67,508
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 4, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 4, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 28, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 28, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 11, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $22.83M (prior year $19.50M) (+17.1% vs Jun 30, 2025)
- Net income: -$6.20M (prior year -$8.65M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.18 (prior year -$0.26) (loss narrowed vs Jun 30, 2025)
Aug 11, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 28, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jun 25, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade NPCE
- Last results release: Aug 11, 2026 (8-K Item 2.02). Previous ones: May 12, 2026, Mar 3, 2026, Nov 4, 2025. Based on that rhythm, the next report is likely around Nov 10, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.14% (largest 4.4%).
- Liquidity: about 130.31K shares (≈$1.67M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $12.78 vs a range of $9.22–$19.60 (34% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 1 sales; latest: Martha Morrell sold 25,000 shares on Dec 15, 2025.
- Latest filings: 10-Q Aug 11, 2026; 8-K Aug 11, 2026; 8-K Jul 28, 2026.
- Share count: 34.32M shares outstanding (Aug 7, 2026), +3.8% vs a year earlier.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
NPCE market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 12.51 | 13.00 | 12.51 | 12.78 | 86.60K |
| Oct 14, 2026 | 12.58 | 13.04 | 12.48 | 12.56 | 90.00K |
| Oct 13, 2026 | 13.06 | 13.27 | 12.68 | 12.68 | 66.80K |
| Oct 12, 2026 | 12.52 | 13.02 | 12.48 | 13.00 | 63.30K |
| Oct 9, 2026 | 12.39 | 12.70 | 12.38 | 12.67 | 72.50K |
| Oct 8, 2026 | 12.66 | 12.66 | 12.28 | 12.39 | 142.60K |
| Oct 7, 2026 | 12.58 | 13.06 | 12.51 | 12.76 | 127.20K |
| Oct 6, 2026 | 13.38 | 13.38 | 12.66 | 12.67 | 83.00K |
| Oct 5, 2026 | 12.64 | 13.26 | 12.50 | 13.22 | 149.40K |
| Oct 2, 2026 | 13.34 | 13.34 | 12.68 | 12.70 | 120.40K |
| Oct 1, 2026 | 13.81 | 13.81 | 13.05 | 13.15 | 197.40K |
| Sep 30, 2026 | 14.02 | 14.06 | 13.73 | 13.76 | 120.90K |
| Sep 29, 2026 | 14.14 | 14.45 | 13.77 | 13.94 | 100.60K |
| Sep 28, 2026 | 14.01 | 14.18 | 13.75 | 14.15 | 134.30K |
| Sep 25, 2026 | 13.95 | 14.18 | 13.75 | 14.06 | 231.40K |
| Sep 24, 2026 | 14.21 | 14.21 | 13.59 | 13.97 | 186.00K |
| Sep 23, 2026 | 14.71 | 14.87 | 14.17 | 14.21 | 166.40K |
| Sep 22, 2026 | 14.75 | 14.94 | 14.54 | 14.71 | 160.20K |
| Sep 21, 2026 | 14.36 | 14.66 | 14.12 | 14.54 | 71.70K |
| Sep 18, 2026 | 14.17 | 14.56 | 14.05 | 14.28 | 235.50K |
About NeuroPace
NeuroPace (NPCE) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in MOUNTAIN VIEW, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1528287.
NPCE board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Lisa Andrade | Director | Jun 5, 2026 |
| Joel Becker | CHIEF EXECUTIVE OFFICER | Sep 4, 2026 |
| Frank M Fischer | Director | Jun 22, 2026 |
| Uri Geiger | Director | Jun 22, 2026 |
| R Scott Huennekens | Director | Jun 5, 2026 |
| Rakhi Kumar | Director | Jun 22, 2026 |
| Joseph Lacob | Director | Mar 24, 2026 |
| Renee Ryan | Director | Jun 5, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Joel Becker | CHIEF EXECUTIVE OFFICER | Sep 4, 2026 |
| Martha Morrell | CHIEF MEDICAL OFFICER | Sep 25, 2026 |
| Patrick F. Williams | Chief Financial Officer | Sep 21, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Dec 15, 2025 | Martha Morrell | Sale | 25,000 | $15.97 |
NPCE financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $99.99M | $-21.46M | -0.66 | $-11.01M |
| Dec 31, 2024 | $79.91M | $-27.14M | -0.93 | $-17.95M |
| Dec 31, 2023 | $65.42M | $-32.96M | -1.27 | $-19.70M |
| Dec 31, 2022 | $45.52M | $-47.08M | -1.91 | $-36.87M |
| Dec 31, 2021 | $45.18M | $-36.08M | -2.17 | $-24.58M |
Latest balance sheet: total assets $96.99M, total liabilities $85.11M, cash $12.54M (as of Jun 30, 2026).
NPCE earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 11, 2026 | 8-K Item 2.02 (results) | $15.05 |
| May 12, 2026 | 8-K Item 2.02 (results) | $15.80 |
| Mar 3, 2026 | 8-K Item 2.02 (results) | $13.83 |
| Nov 4, 2025 | 8-K Item 2.02 (results) | $9.40 |
| Aug 12, 2025 | 8-K Item 2.02 (results) | $9.13 |
| May 13, 2025 | 8-K Item 2.02 (results) | $12.95 |
| Mar 4, 2025 | 8-K Item 2.02 (results) | $11.92 |
| Jan 28, 2025 | 8-K Item 2.02 (results) | $14.13 |
| Jan 8, 2025 | 8-K Item 2.02 (results) | $12.01 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $7.14 |
| Aug 13, 2024 | 8-K Item 2.02 (results) | — |
| May 8, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Stryker (SYK)Boston Scientific (BSX)3M (MMM)MiniMed (MMED)Dexcom (DXCM)Becton Dickinson (BDX)Medline (MDLN)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on NPCE
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.